SEER
Seer Inc - Ordinary Shares - Class A

615
Loading...
Loading...
News
all
press releases
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates
Seer (SEER) delivered earnings and revenue surprises of +15.38% and +8.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
More News
News Placeholder
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
Zacks·5mo ago
News Placeholder
Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates
chainwire·5mo ago
News Placeholder
Insider Selling: Seer, Inc. (NASDAQ:SEER) CEO Sells $107,299.71 in Stock
Seer, Inc. (NASDAQ:SEER Get Free Report) CEO Omid Farokhzad sold 52,857 shares of the firms stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of...
Ticker Report·2y ago
News Placeholder
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer dataREDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life...
Globe Newswire·2y ago
News Placeholder
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Globe Newswire·2y ago
News Placeholder
Seer Proteograph Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci (pQTL) studies Proteograph Product Suite enables...
Globe Newswire·2y ago
News Placeholder
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
REDWOOD CITY, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it...
Globe Newswire·2y ago

Latest SEER News

View

Advertisement|Remove ads.

Advertisement|Remove ads.